Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy

NCT03742193 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma
Pulmonary Metastases
Apatinib

Interventions

DRUG: Apatinib
DRUG: GD regimen

Sponsor

Ruijin Hospital